Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biosig Technologies (BSGM)

Biosig Technologies (BSGM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 187,985
  • Shares Outstanding, K 26,109
  • Annual Sales, $ 0 K
  • Annual Income, $ -34,050 K
  • 60-Month Beta 1.41
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 11.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.24
  • Number of Estimates 1
  • High Estimate -0.24
  • Low Estimate -0.24
  • Prior Year -0.38
  • Growth Rate Est. (year over year) +36.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.71 +7.30%
on 07/09/20
11.15 -35.43%
on 06/17/20
-2.80 (-28.00%)
since 06/10/20
3-Month
4.60 +56.52%
on 04/15/20
12.43 -42.08%
on 05/12/20
+2.03 (+39.26%)
since 04/09/20
52-Week
2.36 +205.08%
on 03/18/20
12.43 -42.08%
on 05/12/20
-1.42 (-16.47%)
since 07/10/19

Most Recent Stories

More News
BioSig Submits Application to Systems for Award Management (SAM) with U.S. Government

BioSig Technologies, Inc. (BSGM) ("BioSig" or the "Company"), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover...

BSGM : 7.20 (+1.27%)
ViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19

BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company") and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced that it is partnering with Albany Molecular Research Inc., (AMRI),...

AMRI : 21.74 (unch)
BSGM : 7.20 (+1.27%)
ViralClear Pharmaceuticals Partners With Albany Molecular Research Inc. (AMRI) on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19

ViralClear Pharmaceuticals, Inc. (ViralClear), supported by Albany Molecular Research Inc., (AMRI), a leading global contract research, development, and manufacturing organization (CDMO), is undertaking...

AMRI : 21.74 (unch)
BSGM : 7.20 (+1.27%)
BioSig Technologies Inc. Appoints Tony Zook to the Board of Directors

BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity...

AZN : 53.76 (-0.39%)
BSGM : 7.20 (+1.27%)
BioSig Technologies, Inc Closes $17.5 Million Common Stock Offering

BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company") and its majority-owned subsidiary, ViralClear Pharmaceuticals, Inc., today announced that it has closed on the sale of 2,187,500 shares...

BSGM : 7.20 (+1.27%)
BioSig Technologies, Inc. Announces $17.5 Million Common Stock Only Registered Direct Offering

BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company") today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase...

BSGM : 7.20 (+1.27%)
ViralClear Partners with Catalent on Potential Treatment for COVID-19

BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company") and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced that it has signed an agreement with Catalent, the leading global...

BSGM : 7.20 (+1.27%)
Are Antivirals For COVID-19 More Likely to Be Developed and Approved Before a Vaccine

, /PRNewswire/ -- Now that confirmed worldwide cases of the global health crisis are continuing to grow, scientists are pushing forward with efforts to develop vaccines and treatments to slow the pandemic...

BSGM : 7.20 (+1.27%)
NVAX : 94.36 (-2.01%)
MRNA : 62.61 (-3.63%)
JNJ : 142.37 (-0.08%)
AZN : 53.76 (-0.39%)
ViralClear Opens Enrollment with First Patient Dosing in Phase II Human Trial of Anti-Viral MMPD Oral Solution for Treatment of COVID-19

BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company") and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced that it has commenced patient enrollment with the dosing of the...

BSGM : 7.20 (+1.27%)
Reminder - BioSig Subsidiary, ViralClear to Host Conference Call on June 9th to Discuss Upcoming and Recent Developments for Phase II Human Clinical Trials of its Broad-Spectrum Oral Anti-Viral Candidate for Treatment of COVID-19

EQNX::TICKER_START (NASDAQ:BSGM),(NASDAQ:BSGM), EQNX::TICKER_END

BSGM : 7.20 (+1.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade BSGM with:

Business Summary

BioSig Technologies is a medical technology company developing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace. The Company's first product, PURE EPTM System is a computerized system intended for acquiring, digitizing, amplifying, filtering,...

See More

Key Turning Points

2nd Resistance Point 7.55
1st Resistance Point 7.37
Last Price 7.20
1st Support Level 6.95
2nd Support Level 6.71

See More

52-Week High 12.43
Fibonacci 61.8% 8.58
Fibonacci 50% 7.39
Last Price 7.20
Fibonacci 38.2% 6.21
52-Week Low 2.36

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar